Interview with the magazine “Laborjournal”
Research and development without or with significantly less animal testing must be possible. We at Dynamic42 are convinced of this and at the same time on the way to realising this goal with the help of our organ-on-chip technology.
In an interview with the trade journal “Laborjournal”, our managing directors Martin Raasch and Knut Rennert explain how the Dynamic42 biotech chips work and how the “mini-organs” used contribute to reducing animal experiments.
The article also gives exciting insights into the background of our company and explains what our company name means.
Read the full interview in German: Laborjounal online: Nerdy names and runny noses
Recommendation: The magazine reported in more detail about our technology in the print edition. Laborjournal issue 03/22 (page 46/47)
Read more News:
News, News-Cancer
Press Release | Dynamic42 and EPO Close the Gap in Brain Cancer Research
Dynamic42 GmbH and EPO Experimental Pharmacology & Oncology are collaborating to advance brain cancer research by integrating organ-on-chip technologies into preclinical drug development.
Read MoreNews, News-TEER
Press Release | Setting a New Benchmark in Functional Barrier Analysis
Dynamic42 announces the launch of its DynamicOrgan® TEER-Sensor System enabling real-time, non-invasive monitoring of barrier integrity within an organ-on-chip model.
Read MoreNews
Press Release | Dynamic42 gewinnt Life-Science-Experten Wolfgang Kintzel als strategischen Berater
Dynamic42 GmbH hat den international erfahrenen Manager Wolfgang Kintzel als strategischen Berater gewonnen.
Read More

